The cannabis sector has been booming in Switzerland since 2016 when the country legalized cannabis flowers containing less than 1% THC as a tobacco substitute. Along with the production, further processing and trading of CBD, the production and export of medical cannabis containing over 1% THC will be permitted from the middle of 2022. Pilot projects are also underway relating to the authorization of cannabis for leisure use and experts are predicting that comprehensive regulation will be achieved within the next three years.
As an addition to the CB Expo (Cannabis Business Expo & Conference), the CB Club is offering a select group the chance to acquire news, insight and new contacts within a refined setting and relaxed atmosphere at one-day networking events.
14 April 2022
23 September 2020
How international laws affect cannabis regulations: the examples of Uruguay and Malta
Moderation:Stefan Martin Meyer (PhytoFlow GmbH)
Speaker: Alfredo Pascual (Seed Innovations) und Andrew Bonello (ReLeaf Malta)
150 episodes of The Cannabis Conversation podcast
Speaker: Anuj Desai (Canverse)
Trichomes of cannabis: their structure, function, and density
Speaker: Dr. Callie Seaman (Aqualabs)
Education: your key to market development
Speaker: Viola Brugnatelli (Cannabiscienza)
Safety and transparency in cannabis products
Speaker: Michela Mastropietro (Swiss Queen GmbH)
Project Manager & Product Owner
Cannavigia/ Vigia AG
Dr. Arno Hazekamp became one of the first cannabis researchers in Europe when he started his PhD on medicinal cannabis in the Netherlands in 2003. As a biochemist, he has worked for Dutch LP Bedrocan, advised the Dutch Office of Medicinal Cannabis, and supported numerous cannabis projects around the world as an independent consultant.
Cannabis consultant for research and education
Legal Cannabis Coalition (LCC)
Lino Cereghetti studied biology and agricultural economics at the ETH Zurich and gained profound business experience both nationally and internationally in start-ups, development and consulting. As COO of Pure Holding AG, he ensures the ongoing strategic and political development of the group. In August 2020, he was elected as a board member of the industry federation IG Hanf, where he is focusing on regulatory affairs.
Pure Holding AG
Board Member, IG Hanf
Daniel Haymann advises companies in the cannabis industry across the entire value chain, including on regulatory matters. He previously gathered extensive experience with two leading commodity trading companies as a commodities trader and in various management roles. He has held posts in Zurich, Baar, Singapore and Hong Kong.
Daniela E. Eigenmann arbeitet als Co-leitende Apothekerin in der Cannabis-Abteilung der Bahnhof Apotheke Langnau, dessen Leitung Dr. Manfred Fankhauser obliegt. Die Bahnhofapotheke Langnau ist eine anerkannte Pionierin im Bereich des medizinischen Cannabis. Daniela E. Eigenmann ist für die Produktion und für den Vertrieb von Cannabismedikamenten, sowie für die Beratung und Betreuung von Patienten zuständig. Als engagierte Referentin setzt sie sich für die therapeutische Anwendung von medizinischem Cannabis ein.
Apothekerin, Co-Leiterin Cannabis-Med-Abteilung
Bahnhof Apotheke Langnau AG
He originally completed a PhD in Biology and a few years worked in marketing at different pharmaceutical companies. For the last two years, he has been working as a research assistant at the Federal Office of Public Health in the field of political foundations & implementation. He is responsible for granting exemption licenses in connection with cannabis containing at least 1% THC. In his role, he is also the contact person for questions relating to cultivation and production for pilot trials.
Swiss Federal Office of Public Health
Michela Mastropietro is a multilingual, young and driven entrepreneur with a dedicated work ethic and ability to implement and manage deliverables in a highly dynamic and complex industry. Michela has worked with leading organizations, acquiring in-depth training in the Swiss financial sector before having had the opportunity to collaborate with notable start-ups and develop scale-ups and strategic partnerships with big players and leading manufacturing companies globally in the up-and-coming cannabis industry. Michela’s mission is driven by the desire to share education and knowledge among industry participants and society in order to provide safe access to cannabis across the globe. “Together we grow.” – Michela Mastropietro
Mitbegründerin & Managing Director
Swiss Queen GmbH
Daniel Donauer is a lawyer at the MLL law firm and specializes in health and medical law issues. In this context, he advises his clients, among other things, about Swiss product implementation (i.e. medicinal products, medications, food, cosmetics issues, other commodities, chemicals and alcohol and tobacco).
LL.M. (Health Law)
CAS (Medicine Law)
Lisa Haag has been working in the cannabis industry since 2017. In July 2018, she founded MJ_UNIVERSE GmbH, a publisher for digital products (e.g. Krautinvest.de) and a collaborative network for connecting companies across the hemp and cannabis value chain She collaborates with a network of specialist experts to provide companies with advice on how to navigate around the cannabis ecosystem in Europe. She has completed an apprenticeship in business administration (IUBH, Bad Honnef) and a Bachelor’s degree in Business (Victoria University, Melbourne) in Hospitality Management. Lisa has been working for many years at companies operating in strategic and regional sales for facility management services (IFM, TFM, CFM, etc.).
A founding member and executive board member of the German professional body BvCW e.V. and an active member of the Cannafem Network – a professional network for women, hemp and cannabis.
Franziska Katterbach is an accomplished business executive and legal expert (zugelassene Rechtsanwältin) who brings extensive experience working within Europe’s emerging cannabis industry. After completing her legal studies at Universität Leipzig and Landgericht Darmstadt, Franziska joined the corporate law firm Dentons, where she was involved in high-profile deals in the cannabis sector across multiple jurisdictions. Franziska later served as Director of Legal for Canopy’s European operations, before joining Khiron. With 8+ years of regulatory expertise and 4+ as business executive in the European emerging cannabis industry, Franziska has well rounded knowledge in the industry. Franziska is considered a pioneer of the medical cannabis market in Germany, working in the medical cannabis industry in Europe on executive level since the very beginning in 2016.
Since 2020, Lito Michael Schulte has been advising large pharmacists, food business operators and distributors specializing in cannabis with economic law issues relating to the German-European regulatory framework. He is currently undertaking a Master’s degree in Commercial Law (LL.M.) at the University of Münster and is working towards a PhD on a topic relating to corporate law.
Stefan Martin Meyer, MBA, was raised in the Italian side of Switzerland, near the city of Lugano. He then moved to Spain where he co-founded Phytoplant Research SL, which was granted the first research license for medicinal cannabis in Spain in 2012. While there he was able to get various R&D grants by the European Union for projects related to cannabinoids and medicine as well as publish results in high impact scientific journals. In 2019 Stefan joined Plena Global Holding Inc (Canada) as Chief Strategy Officer, where he has been leading a project licensed to grow medicinal cannabis in Colombia. In 2020 Stefan founded Phytoflow GmbH, a Swiss based company PhytoFlow GmbH providing experience-driven strategic business advice to companies active in the medical cannabis sector.
Based in Germany, Alfredo is a prominent cannabis industry analyst who has been identifying opportunities and generating unique insights for businesses and investors in Europe and Latin America since 2016. He is currently VP of Investment Analysis of Seed Innovations Ltd (LON: SEED), the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space. Before joining Seed Innovations, Alfredo worked as International Analyst at MJBiz, the leading US-based B2B resource for the cannabis industry, where he focused on covering how markets and investments were evolving internationally. Alfredo has a Bachelor of Business Administration and a Master of Governance and Public Policy.
VP of Investment Analysis
Seed Innovations (LON: SEED)
Andrew Bonello is the President of ReLeaf Malta and has since 2019, has worked tirelessly to represent the voice of cannabis consumers in Malta. Andrew actively meets various local players and international experts to discuss issues related to cannabis, human rights and public health, more specifically advocating for a more just, humane and non-criminal approach. Today, Andrew remains committed to pushing for a truly decriminalized and regulated approach to cannabis, placing the well-being of consumers at the heart of every decision.
Anuj Desai is host of Europe’s leading cannabis industry podcast, The Cannabis Conversation, having interviewed over 150 global cannabis thought leaders. He is a qualified lawyer, having worked in a variety of senior roles in the UK media industry over 15 years and now acts as a legal consultant and board advisor to cannabis start-ups and SMEs in the UK. Anuj has developed and continues to expand an extensive global network in the cannabis, CBD, cannabinoid and hemp sectors.
Viola is a neuroscientist specialised in endocannabinology and cannabinoid pharmacology; she is currently working as a lecturer and researcher on medical cannabis at the Department of Neuroscience, University of Padua and has been running Cannabiscienza Srl since 2018 to solve the cultural gap existing in academy and medical practice in Italy, making her life mission to share scientific knowledge on cannabinoids.
The world of events has become uncertain since the outbreak of the Covid pandemic in spring 2020. The following rules apply to the CB Club in relation to the Covid situation and other epidemics/pandemics:
The CB Company is taking the Covid situation very seriously and is planning the CB Club 2022 in close collaboration with the relevant responsible authorities. A limited number of people inside, sanitizer dispensers at all the key points and mandatory mask wearing and testing, depending on the situation.
The CB Club will take place if allowed by the legally applicable measures governing events in Switzerland at that time and taking into account the international travel situation.
Cancellation / Postponement
If the CB Club has to be cancelled due to Covid, a replacement date will be announced. Any tickets already purchased will be valid on the new date or else a refund can be issued free-of-charge within 10 days of the announcement.
Quarantine / Travel Bans
If travel is not possible due to quarantine regulations or travel bans, we request that customers contact us as soon as possible to find a solution.
In the event of illness, visitors have the option to transfer their tickets to other individuals from their company. A refund cannot be guaranteed in this case.
This website applies cookies to grant you the best possible service. By using this website you accept the insert of cookies. By using this website you accept the insert of cookies. Further information on our data privacy statement you will find here.
10-11 Sept, 2022